FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome March 24, 2023 AutoBot News 0 FDA has approved Joenja (leniolisib) tablets as the first treatment for activated phosphoinositide 3-kinase delta syndrome in adult and pediatric patients 12 years of age and older.